Archive for July, 2009
Friday, July 31st, 2009
The U.S. Food and Drug Administration on Friday approved Onglyza, a once-daily tablet to treat Type 2 diabetes in adults. (Source: Xinhuanet Chinaview Health)
Posted in Obesity and Diabetes | Comments Off
Friday, July 31st, 2009
Obese, but worried that surgery for it might kill you? The risk of that has dropped dramatically, and now is no greater than ... (Source: USATODAY.com Health)
Posted in Obesity and Diabetes | Comments Off
Friday, July 31st, 2009
AstraZeneca and Bristol-Myers Squibb today announced that the US Food and Drug Administration (FDA) has approved ONGLYZA (saxagliptin) for the treatment of type 2 diabetes mellitus in adults. (Source: World Pharma News)
Posted in Obesity and Diabetes | Comments Off
Friday, July 31st, 2009
Being overweight makes it harder to manage your diabetes. Extra pounds can effect how your body uses insulin. Fat cells are more resistant to insulin than muscle cells, so... (Source: About Diabetes)
Posted in Obesity and Diabetes | Comments Off
Friday, July 31st, 2009
Breastfeeding promotion still lags far behind spend on formula milk marketingRelated items from OnMedicaChanges to health visiting service will put kids at risk Government launches its Child Health Strategy Obesity problems begin before conception Poorest Scottish kids do the least exerciseCash-injection for sick children (Source: OnMedica Latest News)
Posted in Obesity and Diabetes | Comments Off
Friday, July 31st, 2009
Conclusion: Failure to establish a patent upper airway by non-surgical means is a rare complication in anesthesia and emergency care. In such a situation, where the oral and nasal route is impossible, cricothyroidotomy is a life-saving skill. Intimate familiarity with the technique and detailed practical knowledge of the anatomy are ...
Posted in Obesity and Diabetes | Comments Off
Friday, July 31st, 2009
ROCKVILLE, Md., July 31, 2009--The U.S. Food and Drug
Administration today approved Onglyza (saxagliptin), a once-daily
tablet to treat Type 2 diabetes in adults. The medication is
intended to be used with diet and exercise to control high... (Source: Drugs.com - New Drug Approvals)
Posted in Obesity and Diabetes | Comments Off
Friday, July 31st, 2009
WASHINGTON (MedPage Today) -- The FDA today approved saxagliptin (Onglyza) for type 2 diabetes treatment, making it the first gliptin-class competitor for sitagliptin (Januvia). (Source: MedPage Today Cardiovascular)
Posted in Obesity and Diabetes | Comments Off
Friday, July 31st, 2009
Authors: Shimabuku R, Teruya A, Nakachi G
Ethnic differences in the pattern and trend of growth and weight have been described in studies of migrant populations. Our objective was to compare anthropometric parameters and overweight prevalence in third and fourth generation Japanese descendant preschoolers within the Peruvian ...
Posted in Obesity and Diabetes | Comments Off
Friday, July 31st, 2009
In conclusion, alcohol consumption is associated with decreased insulin resistance independent of BMI in Japanese community-dwelling men.
PMID: 19638738 [PubMed - in process] (Source: The Tohoku Journal of Experimental Medicine)
Posted in Obesity and Diabetes | Comments Off